Three leaders in longevity biotechnology form a research collaboration

(InSilico Medicine, Inc.) The Buck Institute for Research on Aging, Juvenescence Ltd., and Insilico Medicine announced today that they have entered into a multi-year research collaboration. The collaboration aims to advance the understanding of a new molecular pathway potentially implicated in aging and age-related diseases and to discover and develop molecules to target this pathway.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2P87YWI